The authors also sought to compare bladder function and patient satisfaction after these interventions. Individuals were categorized into 3 groups: 1) CIC-alone, 2) CIC with bladder augmentation cystoplasty (AUG), and 3) CIC with botulinum toxin use (BTX). Multivariate linear regression was used controlling for multiple factors to establish differences in the Neurogenic Bladder Symptom Score (NBSS), sub-domains of the NBSS (Incontinence, Storage & Voiding, Consequences), and the final question of the NBSS (satisfaction with urinary function) between the three managements. Mean time from SCI injury was 14 years.
FREE DAILY AND WEEKLY NEWSLETTERS OFFERED BY CONTENT OF INTEREST
Did you find this article relevant? Subscribe to UroToday-GUOncToday!
The fields of GU Oncology and Urology are advancing rapidly including new treatments, enrolling clinical trials, screening and surveillance recommendations along with updated guidelines. Join us as one of our subscribers who rely on UroToday as their must-read source for the latest news and data on drugs. Sign up today for blogs, video conversations, conference highlights and abstracts from peer-review publications by disease and condition delivered to your inbox and read on the go.
The authors concluded that augmented patients were better in global continence and function than the other two groups. A limitation of the study is that the data is cross sectional; the authors cannot conclude that botox doesn’t work, as they don’t have measure of how patients were prior. The study highlights continued research in the field of neurogenic bladder.
Source of Funding: PCORI CER14092138
Presented by: Jeremy B Myers, MD, FACS¹
Co-Authors: Sara Lenherr MD, MS², John Stoffel MD³, Sean Elliott MD, MS⁴, Angela Presson PhD, MS⁵, Chong Zhang MS⁵, Darshan Patel MD⁵, Amitabh Jha MD, MPH⁵, Jeffrey Rosenbluth MD⁵ and Blayne Welk MD, MSc⁶
1. University of Utah
2. University of Utah, Salt Lake City, UT
3. University of Michigan, Ann Arbor, MI
4. University of Minnesota, Minneapolis, MN
5. University of Utah, Salt Lake City, UT
6. Western University, London, Ontario, CAN
Written by: Cristina Palmer, DO. Female Urology, Pelvic Reconstruction, Voiding Dysfunction Fellow, Department of Urology, UC Irvine Medical Center, Orange, California at the Society of Urodynamics, Female Pelvic Medicine & Urogenital Reconstruction Winter Meeting (SUFU 2018), February 27-March 3, 2018, Austin, Texas